Therefore, we focused on screening for 2 α-globin gene mutations. The sensitivity,
specificity, PPV and NPV of each selected cut-off point in screening for 2 α-globin gene defects, 2 α-globin gene deletions and heterozygous α0-thalassemia were summarized (Table 3)